RESEARCH IN MOTION (RIMM) ON WAY TO $20 (MSFT), (AAPL), (GOOG)

Readers may want to start from my previous article on Research In Motion titled What Is The True Value Of Research In Motion? In the article I described various scenarios for Research In Motion (RIMM). One of the scenarios I described was for Research in Motion to continue on its

Read More

ACORDA THERAPEUTICS (ACOR): TIME TO TAKE PROFITS

It is time to take profits on Acorda Therapeutics (ACOR).   Consider  taking profits on the entire position of Acorda Therapeutics right here at $23.08. Ampyra, the drug that has caused most excitement  in Acora  Therapeutics, is not proving to be a very good drug as we had predicted.  

Read More

BROADCOM (BRCM) BUYS NETLOGIC (NETL)

Broadcom (BRCM) is acquiring  NetLogic  (NETL) for approximately $3.7 billion.   NetLogic share holders will receive $50 per share.   Broadcom expects the acquisition to be accretive by approximately $1.10.   Broadcom also reaffirmed its business outlook for Q3. Those holding NetLogic may consider continuing to hold it until the

Read More

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content